UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Sequential targeting of interferon pathways for increased host resistance to bacterial superinfection during influenza

PLoS pathogens, 2021-03, Vol.17 (3), p.e1009405

2021

Volltextzugriff (PDF)

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes

PLoS neglected tropical diseases, 2015-12, Vol.9 (12), p.e0004255

2015

Volltextzugriff (PDF)

Novel azoles with potent antileishmanial activity

Future microbiology, 2021-08, Vol.16 (12), p.871-877

2021

Volltextzugriff (PDF)

Novel fluorobenzothiazole as a dual inhibitor of gyrase B and topoisomerase IV against Gram-positive pathogens

Future microbiology, 2023-07, Vol.18 (10), p.625-638

2023

Volltextzugriff (PDF)

Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients

Journal of clinical virology, 2021-08, Vol.141, p.104879-104879, Article 104879

2021

Volltextzugriff (PDF)

Disease Tolerance during Viral-Bacterial Co-Infections

Viruses, 2021-11, Vol.13 (12), p.2362

2021

Volltextzugriff (PDF)

Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies

PloS one, 2013-05, Vol.8 (5), p.e64595-e64595

2013

Volltextzugriff (PDF)

ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs

Pharmaceutics, 2023-04, Vol.15 (4), p.1212

2023

Volltextzugriff (PDF)

Azithromycin Exhibits Activity Against Pseudomonas aeruginosa in Chronic Rat Lung Infection Model

Frontiers in microbiology, 2021-04, Vol.12, p.603151-603151

2021

Volltextzugriff (PDF)

In Vitro and In Vivo Activities of the Novel Ketolide RBx 14255 against Clostridium difficile

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5986-5989

2012

Volltextzugriff (PDF)

Non invasive real-time monitoring of bacterial infection & therapeutic effect of anti-microbials in five mouse models

Indian journal of medical research (New Delhi, India : 1994), 2011-11, Vol.134 (5), p.688

2011

Volltextzugriff (PDF)

Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination

JCI insight, 2022-06, Vol.7 (11)

2022

Volltextzugriff (PDF)

Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile

Journal of antimicrobial chemotherapy, 2011-05, Vol.66 (5), p.1087-1095

2011

Volltextzugriff (PDF)

High content screening strategies for large-scale compound libraries with a focus on high-containment viruses

Antiviral research, 2024-01, Vol.221, p.105764-105764, Article 105764

2024

Volltextzugriff (PDF)

A Novel Ketolide, RBx 14255, with Activity against Multidrug-Resistant Streptococcus pneumoniae

Antimicrobial agents and chemotherapy, 2014-08, Vol.58 (8), p.4283-4289

2014

Volltextzugriff (PDF)

Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: in vitro and in vivo studies

Drug development and industrial pharmacy, 2019-03, Vol.45 (3), p.395-404

2019

Volltextzugriff (PDF)

The PB1-F2 virulence protein regulates host ILC2 responses during influenza

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.148-148.38

2020

Volltextzugriff (PDF)

Concomitant Delivery of Paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy

Nanomedicine, 2018-06, Vol.14 (4), p.1301-1313

2018

Volltextzugriff (PDF)

Viral PB1-F2 and host IFN-γ guide ILC2 and T cell activity during influenza virus infection

Proceedings of the National Academy of Sciences - PNAS, 2022-02, Vol.119 (8)

2022

Volltextzugriff (PDF)

In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

Novel FtsZ inhibitor with potent activity against Staphylococcus aureus

Journal of antimicrobial chemotherapy, 2021-10, Vol.76 (11), p.2867-2874

2021

Volltextzugriff (PDF)

Utilization of Bombyx mori larvae as a surrogate animal model for evaluation of the anti-infective potential of oxazolidinones

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2008-04, Vol.14 (2), p.166-169

2008

Volltextzugriff (PDF)

In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model

International journal of antimicrobial agents, 2009-03, Vol.33 (3), p.280-284

2009

Volltextzugriff (PDF)

DS86760016, a Leucyl-tRNA Synthetase Inhibitor with Activity against Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)
Buchkapitel
(1)

Sprache

Englisch
(40)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Sequential targeting of interferon pathways for increased host resistance to bacterial superinfection during influenza

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes

Novel azoles with potent antileishmanial activity

Novel fluorobenzothiazole as a dual inhibitor of gyrase B and topoisomerase IV against Gram-positive pathogens

Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients

Disease Tolerance during Viral-Bacterial Co-Infections

Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies

ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs

Azithromycin Exhibits Activity Against Pseudomonas aeruginosa in Chronic Rat Lung Infection Model

In Vitro and In Vivo Activities of the Novel Ketolide RBx 14255 against Clostridium difficile

Non invasive real-time monitoring of bacterial infection & therapeutic effect of anti-microbials in five mouse models

Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination

Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile

High content screening strategies for large-scale compound libraries with a focus on high-containment viruses

A Novel Ketolide, RBx 14255, with Activity against Multidrug-Resistant Streptococcus pneumoniae

Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: in vitro and in vivo studies

The PB1-F2 virulence protein regulates host ILC2 responses during influenza

Concomitant Delivery of Paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy

Viral PB1-F2 and host IFN-γ guide ILC2 and T cell activity during influenza virus infection

In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile

Novel FtsZ inhibitor with potent activity against Staphylococcus aureus

Utilization of Bombyx mori larvae as a surrogate animal model for evaluation of the anti-infective potential of oxazolidinones

In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus

Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model

DS86760016, a Leucyl-tRNA Synthetase Inhibitor with Activity against Pseudomonas aeruginosa

Suchergebnisse filtern